Skip to content
2000
image of Reduced Erythrocyte Opsonization by Calreticulin, Lactadherin, Mannose-binding Lectin, and Thrombospondin-1 in MAFLD Patients

Abstract

Introduction

Metabolism dysfunction associated with fatty liver disease During metabolic hepatic inflammation (MAFLD), is characterized by systemic metabolism deregulation leading to increased hepatic erythrophagocytosis and subsequent iron overload and ferroptosis. Studies in animal models have shown that erythrocyte phosphatidylserine exposure drives erythrophagocytosis. However, the mechanism of erythrophagocytosis in human MAFLD has not been fully elucidated yet. Therefore, in this study, we explored the opsonins recognizing phosphatidylserine. In particular, we measured the levels of erythrocyte calreticulin, lactadherin, mannose-binding lectin, and thrombospondin-1.

Methods

Twenty-four patients (15 men and 9 women) with MAFLD and 9 healthy controls (4 men and 5 women) were enrolled. Erythrocytes were isolated from EDTA-containing blood through multiple centrifugations and isotonic buffer. Protein levels were measured in erythrocyte lysates (triton X-100 0.1% v/v) or plasma with enzyme-linked immunosorbent assays.

Results

Erythrocyte TSP-1 levels were reduced in MAFLD patients. This reduction was not followed by changes in plasma TSP-1 levels or erythrocyte calreticulin, lactadherin, and mannose-binding protein

Discussion

Our results suggest that erythrophagocytosis in human MALFD, unlike animal models, is not mediated by opsonization of exposed phosphatidylserine.

Conclusion

Our study underlines the need for disease models that could better reflect the molecular pathogenesis of human MAFLD.

Loading

Article metrics loading...

/content/journals/chddt/10.2174/011871529X381576250613041457
2025-06-24
2025-09-25
Loading full text...

Full text loading...

References

  1. Papadopoulos C. Panopoulou M. Anagnostopoulos K. Tentes I. Immune and Metabolic Interactions of Human Erythrocytes: A Molecular Perspective. Endocr. Metab. Immune Disord. Drug Targets 2021 21 5 843 853 10.2174/1871530320666201104115016 33148159
    [Google Scholar]
  2. Papadopoulos C. Tentes I. Anagnostopoulos K. Lipotoxicity Disrupts Erythrocyte Function: A Perspective. Cardiovasc. Hematol. Disord. Drug Targets 2021 21 2 91 94 10.2174/1871529X21666210719125728 34825642
    [Google Scholar]
  3. Papadopoulos C. Erythrocyte Glucotoxicity Results in Vascular Inflammation. Endocr. Metab. Immune Disord. Drug Targets 2022 22 9 901 903 10.2174/1871530322666220430013334 35507805
    [Google Scholar]
  4. Otogawa K. Kinoshita K. Fujii H. Sakabe M. Shiga R. Nakatani K. Ikeda K. Nakajima Y. Ikura Y. Ueda M. Arakawa T. Hato F. Kawada N. Erythrophagocytosis by liver macrophages (Kupffer cells) promotes oxidative stress, inflammation, and fibrosis in a rabbit model of steatohepatitis: implications for the pathogenesis of human nonalcoholic steatohepatitis. Am. J. Pathol. 2007 170 3 967 980 10.2353/ajpath.2007.060441 17322381
    [Google Scholar]
  5. Park J.B. Ko K. Baek Y.H. Kwon W.Y. Suh S. Han S.H. Kim Y.H. Kim H.Y. Yoo Y.H. Pharmacological Prevention of Ectopic Erythrophagocytosis by Cilostazol Mitigates Ferroptosis in NASH. Int. J. Mol. Sci. 2023 24 16 12862 10.3390/ijms241612862 37629045
    [Google Scholar]
  6. Papadopoulos C. Mimidis K. Tentes I. Tente T. Anagnostopoulos K. Validation and application of a protocol for the extraction and quantitative analysis of sphingomyelin in erythrocyte membranes of patients with non-alcoholic fatty liver disease. J. Planar Chromatogr. Mod. TLC 2021 34 5 411 418 10.1007/s00764‑021‑00127‑3
    [Google Scholar]
  7. Papadopoulos C. Spourita E. Mimidis K. Kolios G. Tentes L. Anagnostopoulos K. Nonalcoholic Fatty Liver Disease Patients Exhibit Reduced CD47 and Increased Sphingosine, Cholesterol, and Monocyte Chemoattractant Protein-1 Levels in the Erythrocyte Membranes. Metab. Syndr. Relat. Disord. 2022 20 7 377 383 10.1089/met.2022.0006 35532955
    [Google Scholar]
  8. Dupuis L. Chauvet M. Bourdelier E. Dussiot M. Belmatoug N. Le Van Kim C. Chêne A. Franco M. Phagocytosis of Erythrocytes from Gaucher Patients Induces Phenotypic Modifications in Macrophages, Driving Them toward Gaucher Cells. Int. J. Mol. Sci. 2022 23 14 7640 10.3390/ijms23147640 35886988
    [Google Scholar]
  9. Föller M. Lang F. Ion Transport in Eryptosis, the Suicidal Death of Erythrocytes. Front. Cell Dev. Biol. 2020 8 597 10.3389/fcell.2020.00597 32733893
    [Google Scholar]
  10. Cockram T.O.J. Dundee J.M. Popescu A.S. Brown G.C. The Phagocytic Code Regulating Phagocytosis of Mammalian Cells. Front. Immunol. 2021 12 629979 10.3389/fimmu.2021.629979 34177884
    [Google Scholar]
  11. R: A language and environment for statistical computing. 2014 Available from: https://www.semanticscholar.org/paper/R%3A-A-language-and-environment-for-statistical-Team/659408b243cec55de8d0a3bc51b81173007aa89b
  12. Welch B.L. The generalisation of student’s problems when several different population variances are involved. Biometrika 1947 34 1-2 28 35 10.1093/biomet/34.1‑2.28 20287819
    [Google Scholar]
  13. Gignac G.E. Szodorai E.T. Effect size guidelines for individual differences researchers. Pers. Individ. Dif. 2016 102 102 74 78 10.1016/j.paid.2016.06.069
    [Google Scholar]
  14. Papadopoulos C. Tentes I. Anagnostopoulos K. Erythrocytes Contribute to the Immunometabolic Cross-Talk. Immunometabolism 2021 3 2 e210015 10.20900/immunometab20210015
    [Google Scholar]
  15. PAPADOPOULOS C TENTES I, ANAGNOSTOPOULOS K. Red Blood Cell Dysfunction in Non-Alcoholic Fatty Liver Disease: Marker and Mediator of Molecular Mechanisms. Maedica (Buchar.) 2020 15 4 513 516
    [Google Scholar]
  16. Liu W. Östberg N. Yalcinkaya M. Dou H. Endo-Umeda K. Tang Y. Hou X. Xiao T. Fidler T.P. Abramowicz S. Yang Y.G. Soehnlein O. Tall A.R. Wang N. Erythroid lineage Jak2V617F expression promotes atherosclerosis through erythrophagocytosis and macrophage ferroptosis. J. Clin. Invest. 2022 132 13 e155724 10.1172/JCI155724 35587375
    [Google Scholar]
  17. Burger P. Hilarius-Stokman P. de Korte D. van den Berg T.K. van Bruggen R. CD47 functions as a molecular switch for erythrocyte phagocytosis. Blood 2012 119 23 5512 5521 10.1182/blood‑2011‑10‑386805 22427202
    [Google Scholar]
  18. Green J.M. Zheleznyak A. Chung J. Lindberg F.P. Sarfati M. Frazier W.A. Brown E.J. Role of cholesterol in formation and function of a signaling complex involving alphavbeta3, integrin-associated protein (CD47), and heterotrimeric G proteins. J. Cell Biol. 1999 146 3 673 682 10.1083/jcb.146.3.673 10444074
    [Google Scholar]
  19. Yang J. Xing F. Hu F. Hou M. Dong H. Cheng J. Li W. Yan R. Xu J. Xu K. Pan L. Super-resolution microscopy unveils the nanoscale organization and self-limiting clustering of CD47 in human erythrocytes. J. Mol. Cell Biol. 2025 16 9 mjae041 10.1093/jmcb/mjae041 39367479
    [Google Scholar]
/content/journals/chddt/10.2174/011871529X381576250613041457
Loading
/content/journals/chddt/10.2174/011871529X381576250613041457
Loading

Data & Media loading...


  • Article Type:
    Research Article
Keywords: erythrophagocytosis ; Erythrocyte ; immunometabolism ; MAFLD ; opsonization ; thrombospondin
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test